moxisylyte has been researched along with Adenohypophyseal Hyposecretion in 1 studies
Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Damluji, S | 1 |
| Iveson, T | 1 |
| Thomas, JM | 1 |
| Pendlebury, DJ | 1 |
| Rees, LH | 1 |
| Besser, GM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Acute Response of Glucocorticoids Upon Food Intake[NCT04482738] | 36 participants (Actual) | Observational | 2020-05-14 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for moxisylyte and Adenohypophyseal Hyposecretion
| Article | Year |
|---|---|
Food-induced cortisol secretion is mediated by central alpha-1 adrenoceptor modulation of pituitary ACTH secretion.
Topics: Adrenocorticotropic Hormone; Adult; Eating; Humans; Hydrocortisone; Hypopituitarism; Male; Methoxami | 1987 |